Adiuvo Pharmaceuticals Private Limited
About Adiuvo Pharmaceuticals Private Limited
Data last updated:
Adiuvo Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 30 August 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24297MH2011PTC221427.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Rajendra Prasad Agrawal and Atik Goyal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 58/60 Everest House III Rd Floor Vithalwadi Kalba Devi, Mumbai, Maharashtra, India – 400002.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Adiuvo Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address58/60 Everest House III Rd Floor Vithalwadi Kalba Devi, Mumbai, Maharashtra, India – 400002
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Adiuvo Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Adiuvo Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Adiuvo Pharmaceuticals Private Limited, buy the company report.
Financials of Adiuvo Pharmaceuticals Private Limited
FY 2025 filings availableAdiuvo Pharmaceuticals Private Limited reported revenue of ₹285 (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 6% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 67%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Adiuvo Pharmaceuticals Private Limited, buy the company report.
Board of directors of Adiuvo Pharmaceuticals Private Limited
Adiuvo Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendra Prasad Agrawal | Director | 13 Jul 2012 | 14 Years 3 Months | Current |
| Atik Goyal | Director | 30 Aug 2011 | 15 Years 2 Months | Current |
Auditor
Adiuvo Pharmaceuticals Private Limited is audited by PANKAJ NEVATIA & COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PANKAJ NEVATIA & COMPANY | FY 2017 | 011154C |
Shareholding
The shareholding of Adiuvo Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Adiuvo Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Adiuvo Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adiuvo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Adiuvo Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Adiuvo Pharmaceuticals Private Limited has 3 board changes on record since 2011: 2 appointments and 1 cessation. The latest: Nidhi Shrivastava ceased to be Director on 15 Mar 2019.
Frequently asked questions
Adiuvo Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in chemical products, within the chemicals industry. It was incorporated on 30 August 2011 (15+ years old) and is registered under CIN U24297MH2011PTC221427.
Adiuvo Pharmaceuticals has 2 current directors:
- Rajendra Prasad Agrawal - Director
- Atik Goyal - Director
The latest financial statements of Adiuvo Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Adiuvo Pharmaceuticals is U24297MH2011PTC221427. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adiuvo Pharmaceuticals was incorporated on 30 August 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
Nidhi Shrivastava ceased to be Director on 15 Mar 2019. Rajendra Prasad Agrawal was appointed as Director on 13 Jul 2012. Atik Goyal was appointed as Director on 30 Aug 2011.
The registered office of Adiuvo Pharmaceuticals is at 5860 Everest House III Rd Floor Vithalwadi Kalba Devi, Mumbai, Maharashtra, India – 400002.
Adiuvo Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
The compliance status of Adiuvo Pharmaceuticals is compliant as of 08 July 2026. The company is actively filing with the Registrar of Companies.
Adiuvo Pharmaceuticals can be reached at its registered office: 5860 Everest House III Rd Floor Vithalwadi Kalba Devi, Mumbai, Maharashtra, India – 400002.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
